CAR T-cell therapy is starting to enter the treatment conversations sooner with patients with multiple myeloma, according to ...

Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...

Background: Multiple myeloma (MM) is the second most common hematological malignancy that still lacks effective clinical treatments. In particular, MM with central nervous system (CNS) invasion occurs ...